Fig. 5From: Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cellsNetwork based interpretation of DEGs. Venn diagram scheme of Huh7 network nodes (A). Dendogram of GO enrichments for Huh7 (B). Network representation of PI3Ki-β and Sorafenib treated Huh7 cells (C). Dendogram of GO enrichments for Mahlavu (D). Venn diagram scheme of Mahlavu network nodes (E). Network representation of PI3Ki-β and Sorafenib treated Mahlavu cells (F). ALPHA; PI3Ki-α inhibitor, SALPHA; PI3Ki-α inhibitor and SOR, SBETA; PI3Ki-β inhibitor and SOR, SOR; Sorafenib treatmentsBack to article page